Physician profile
Robert Buckenberger
NPI 1063594778
$20,773.98
in general payments reported to CMS, 2019-2025
16 companies · $13K in 2025
The $13K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.19 · 2020: $186 · 2021: $145 · 2022: $3,398 · 2023: $3,135 · 2024: $639 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,519 · Consulting Fee: $6,163 · Food and Beverage: $3,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,519.45 |
| Consulting Fee | $6,162.50 |
| Food and Beverage | $3,315.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $17,810.36 | 2022-2025 | |
| Paragon 28, INC. | $1,055.48 | 2020-2022 | |
| Nevro Corp. | $542.74 | 2021-2024 | Senza |
| Arthrex, INC. | $278.08 | 2023 | |
| Cornerstone Medical Associates, INC. | $250.20 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $181.84 | 2022-2023 | Seglentis |
| Smith+Nephew, INC. | $180.77 | 2019-2025 | Collagenase Santyl |
| Medtronic, INC. | $160.37 | 2022-2024 | Intellis Adaptivestim |
| Stryker Corporation | $155.96 | 2024-2025 | Ortholoc 2 Lapifuse, Prostep, Dart-Fire |
| Paratek Pharmaceuticals, INC. | $37.03 | 2024-2025 | Nuzyra |
| Bioventus LLC | $32.01 | 2022 | |
| Orthofix Medical, INC. | $25.47 | 2019-2022 | |
| Alfasigma USA, INC. | $20.38 | 2021 | |
| Osiris Therapeutics INC. | $17.00 | 2019 | |
| Globus Medical, INC. | $14.01 | 2025 | Senza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Buckenberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.